ProCE Banner Activity

我对病毒学失败患者使用多替拉韦的看法:来自 CROI 2022 的数据

Conference Coverage
Clinical Thought
最近为支持在二线 HIV 治疗中使用多替拉韦而举行了 CROI 2022 虚拟会议,请阅读我对该会议产生的新数据的看法。

Share

Faculty

Yan Zhao

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

由 Gilead Sciences, Inc. 提供的教育补助金 支持。 Janssen Therapeutics,Janssen Products, LP 的事业部 Merck & Co., Inc. ViiV Healthcare

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Yan Zhao, MD

Professor
Division of HIV/AIDS Treatment and Care
National Center for AIDS/STD Control and Prevention
Beijing, China

医学博士 Yan Zhao 没有相关的利益冲突要报告。